Skip to main content
. 2017 Aug 7;8(49):85452–85462. doi: 10.18632/oncotarget.20008

Table 4. Differences in Dietary Inflammatory Index (DII) according to histopathological types among the gastric cancer patients (n=301).

All types (n=301) Intestinal type (n=146) Diffuse type (n=155)
No. of Controls, n (%) No. of Cases, n (%) Crude OR (95% CI) Multi- variable OR (95% CI) p for int. No. of Cases, n (%) Crude OR (95% CI) Multi- variable OR (95% CI) p for int. No. of Cases, n (%) Crude OR (95% CI) Multi-variable OR (95% CI) p for int.
Total 776
(72.05)
301
(27.95)
146
(48.50)
155 (51.50)
 T1 258 (33.25) 71
(23.59)
1.0 (ref) 1.0 (ref) 29 (19.86) 1.0 (ref) 1.0 (ref) 42 (27.10) 1.0 (ref) 1.0 (ref)
 T2 259 (33.38) 85 (28.24) 1.19
(0.83, 1.71)
1.42
(0.95, 2.12)
41 (28.08) 1.41
(0.85, 2.34)
1.86
(1.04, 3.32)
44 (28.39) 1.04
(0.66, 1.65)
1.14
(0.70, 1.86)
 T3 259 (33.38) 145 (48.17) 2.03
(1.46, 2.84)
1.86
(1.28, 2.70)
76 (52.05) 2.61
(1.65, 4.14)
2.33
(1.37 3.96)
69
(44.52)
1.64
(1.08, 2.49)
1.49
(0.95, 2.35)
p-value
for trend
<0.001 0.001 <0.001 0.002 0.017 0.077
Sex
Men 498 (72.07) 193 (27.93) 0.029 122
(83.56)
0.142 71 (45.81)
 T1 144 (28.92) 44 (22.80) 1.0 (ref) 1.0 (ref) 23
(18.85)
1.0 (ref) 1.0 (ref) 21 (29.58) 1.0 (ref) 1.0 (ref)
 T2 156
(31.33)
52 (26.94) 1.09
(0.69, 1.73)
1.40
(0.82, 2.38)
37 (30.33) 1.49
(0.84, 2.62)
2.19
(1.12, 4.28)
15 (21.13) 0.66
(0.33, 1.33)
0.76
(0.36, 1.60)
0.037
 T3 198 (39.76) 97 (50.26) 1.60
(1.06, 2.43)
1.55
(0.95, 2.52)
62 (50.82) 1.96
(1.16, 3.31)
2.03
(1.09, 3.77)
35 (49.30) 1.21
(0.68, 2.17)
1.09
(0.57, 2.05)
p-value
for trend
0.017 0.086 0.011 0.046 0.399 0.724
Women 278 (72.02) 108 (27.98) 24 (16.44) 84 (54.19)
 T1 114 (41.01) 27 (25.00) 1.0 (ref) 1.0 (ref) 6 (25.00) 1.0 (ref) 1.0 (ref) 21 (25.00) 1.0 (ref) 1.0 (ref)
 T2 103
(37.05)
33 (30.56) 1.35
(0.76, 2.40)
1.41
(0.75, 2.67)
4 (16.67) 0.74
(0.20, 2.69)
0.67
(0.16, 2.77)
29 (34.52) 1.53
(0.82, 2.85)
1.61
(0.81, 3.21)
 T3 61 (21.94) 48 (44.04) 3.32
(1.89, 5.84)
3.25
(1.75, 6.05)
14 (58.33) 4.36
(1.60, 11.92)
4.87
(1.47, 16.07)
34 (40.48) 3.03
(1.62, 5.66)
2.93
(1.47, 5.84)
p-value
for trend
<0.001 <0.001 0.003 0.008 0.001 0.002
H. pylori
infection
Positive 478 (63.65) 273 (36.35) 0.126 129
(88.36)
0.438 144 (92.90)
 T1 158 (33.05) 66 (24.18) 1.0 (ref) 1.0 (ref) 26 (20.16) 1.0 (ref) 1.0 (ref) 40 (27.78) 1.0 (ref) 1.0 (ref)
 T2 150 (31.38) 78 (28.57) 1.25
(0.84, 1.85)
1.45
(0.95, 2.23)
36 (27.91) 1.46
(0.84, 2.53)
1.85
(0.98, 3.51)
42 (29.17) 1.11
(0.68, 1.80)
1.19
(0.71, 1.98)
0.164
 T3 170 (35.56) 129 (47.25) 1.82
(1.26, 2.62)
1.69
(1.13, 2.51)
67 (51.94) 2.40
(1.45, 3.96)
2.16
(1.21, 3.87)
62 (43.06) 1.44
(0.92, 2.27)
1.37
(0.85, 2.21)
p-value
for trend
0.001 0.012 <0.001 0.012 0.106 0.196
Negative 298 (91.41) 28
(8.59)
17
(11.64)
11 (7.10)
 T1 100
(33.56)
5
(17.86)
1.0 (ref) 1.0 (ref) 3
(17.65)
1.0 (ref) 1.0 (ref) 2 (18.18) 1.0 (ref) 1.0 (ref)
 T2 109
(36.58)
7 (25.00) 1.28
(0.40, 4.18)
1.32
(0.38, 4.62)
5 (29.41) 1.53
(0.36, 6.56)
1.85
(0.39, 8.77)
2 (18.18) 0.92
(0.13, 6.64)
0.82
(0.10, 6.62)
 T3 89 (29.87) 16 (57.14) 3.60
(1.27, 10.21)
3.50
(1.14, 10.75)
9
(52.94)
3.37
(0.89, 12.84)
3.61
(0.86, 15.19)
7 (63.64) 3.93
(0.80, 19.42)
3.66
(0.66, 20.39)
p-value
for trend
0.009 0.016 0.057 0.065 0.057 0.076

Adjusted for total caloric intake, body mass index, education, smoking (pack year), ethanol amount, physical activity, H. pylori infection, and first-degree family history of gastric cancer; The tertile ranges of DII were categorized based on the distribution of the control group (T1: <0.96, T2: 0.96-2.97, T3: ≥2.97); p for int.: p-value for interaction.